Lunasin decreased skin tumor incidence in the SENCAR mice skin cancer model by ~70% when topically applied at a dose of 250 μg, and promoted colony suppression of mammalian cells induced by carcinogens and viral oncogenes E1A and RAS by 30–43% [11,12,114,115,116,117]. Here, DHTKD1 is linked to skin neoplasm.